Cervical cancer cases are on the decline in the U.S. thanks to increased screening and vaccination with Merck & Co.’s Gardasil. Now, the New Jersey pharma has shown that for patients who unfortunately ...

On the verge of a $43 billion powerhouse merger with Pfizer, Seagen has two Presidential Symposium presentations at the European Society of Medical Oncology (ESMO) Congress in Madrid, further evidence ...

MADRID -- Results from a pair of international phase III trials testing two distinct treatment strategies will usher in new standards of care for women with newly diagnosed, locally advanced cervical ...

Adding pembrolizumab (Keytruda) to chemotherapy with or without bevacizumab (Avastin) significantly slowed progression of metastatic cervical cancer and improved overall survival (OS), investigators ...

MADRID — New data on immunotherapies and targeted therapies in a wide range of cancers, as well as novel chemotherapy regimens, will feature alongside key themes on oncology workforce resilience and ...

PARIS — The launch of the Europe-wide Cancer Prevention Across Europe campaign (PrEvCan) was announced at the opening session of the 2022 Congress of the European Society for Medical Oncology (ESMO).